SG11201610349SA - Dosing regimens for treating and/or preventing cerebral amyloidoses - Google Patents
Dosing regimens for treating and/or preventing cerebral amyloidosesInfo
- Publication number
- SG11201610349SA SG11201610349SA SG11201610349SA SG11201610349SA SG11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA SG 11201610349S A SG11201610349S A SG 11201610349SA
- Authority
- SG
- Singapore
- Prior art keywords
- treating
- dosing regimens
- preventing cerebral
- cerebral amyloidoses
- amyloidoses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461979408P | 2014-04-14 | 2014-04-14 | |
| US14/684,967 US9675627B2 (en) | 2014-04-14 | 2015-04-13 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
| PCT/US2015/025733 WO2015160796A1 (en) | 2014-04-14 | 2015-04-14 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610349SA true SG11201610349SA (en) | 2017-01-27 |
Family
ID=53015935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610349SA SG11201610349SA (en) | 2014-04-14 | 2015-04-14 | Dosing regimens for treating and/or preventing cerebral amyloidoses |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9675627B2 (ja) |
| EP (1) | EP3131547A1 (ja) |
| JP (1) | JP6662789B2 (ja) |
| KR (1) | KR20170003576A (ja) |
| CN (1) | CN107148270A (ja) |
| AU (1) | AU2015247859B2 (ja) |
| CA (1) | CA2945707A1 (ja) |
| HK (1) | HK1243643A1 (ja) |
| SG (1) | SG11201610349SA (ja) |
| WO (1) | WO2015160796A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2490712T3 (en) * | 2009-10-19 | 2015-10-05 | Amicus Therapeutics Inc | PROCESS FOR THE TREATMENT OF ALZHEIMER'S DISEASE BY USING Pharmacological chaperones TO INCREASE ACTIVITY OF GANGLIOSIDASER |
| AR106977A1 (es) | 2015-12-14 | 2018-03-07 | Amicus Therapeutics Inc | Compuestos para el tratamiento de la enfermedad de alzheimer y/o la angiopatía amiloide cerebral |
| US20220184185A1 (en) | 2018-07-25 | 2022-06-16 | Modernatx, Inc. | Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4407957A (en) | 1981-03-13 | 1983-10-04 | Damon Corporation | Reversible microencapsulation of a core material |
| DE69221484T2 (de) | 1991-04-25 | 1998-02-19 | Univ Brown Res Found | Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte |
| US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| CZ286632B6 (cs) | 1992-09-29 | 2000-05-17 | Inhale Therapeutic Systems | Farmaceutický prostředek |
| FR2718357B1 (fr) | 1994-04-06 | 1997-10-03 | Defarges Alain Moreau | Perfectionnements apportés à un dispositif d'injection par jet sans aiguille. |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| WO2004103368A1 (en) | 2003-05-22 | 2004-12-02 | The Hospital For Sick Children | Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| EP1888068B1 (en) | 2005-06-08 | 2014-05-21 | Amicus Therapeutics, Inc. | Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes |
| PL2533050T6 (pl) * | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
| WO2007150064A2 (en) | 2006-06-23 | 2007-12-27 | Amicus Therapeutics, Inc. | METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE |
| MX2009011473A (es) | 2007-04-26 | 2010-01-18 | Amicus Therapeutics Inc | Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas. |
| WO2011011181A1 (en) | 2009-07-01 | 2011-01-27 | Amicus Therapeutics, Inc. | Pharmacological chaperones for the treatment of alzheimer's disease |
| DK2490712T3 (en) * | 2009-10-19 | 2015-10-05 | Amicus Therapeutics Inc | PROCESS FOR THE TREATMENT OF ALZHEIMER'S DISEASE BY USING Pharmacological chaperones TO INCREASE ACTIVITY OF GANGLIOSIDASER |
| CN107088225A (zh) * | 2011-03-11 | 2017-08-25 | 阿米库斯治疗学公司 | 治疗法布里病的给药方案 |
| JP6320931B2 (ja) * | 2011-12-22 | 2018-05-09 | セントジーン アイピー ゲーエムベーハー | リソソーム酵素を再構成する能力を有する化合物ならびにアンブロキソールおよび／またはアンブロキソールの誘導体の組み合わせ |
| US20150086530A1 (en) * | 2012-05-03 | 2015-03-26 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of pompe disease |
-
2015
- 2015-04-13 US US14/684,967 patent/US9675627B2/en active Active
- 2015-04-14 WO PCT/US2015/025733 patent/WO2015160796A1/en active Application Filing
- 2015-04-14 JP JP2016562965A patent/JP6662789B2/ja not_active Expired - Fee Related
- 2015-04-14 AU AU2015247859A patent/AU2015247859B2/en not_active Ceased
- 2015-04-14 KR KR1020167031756A patent/KR20170003576A/ko unknown
- 2015-04-14 EP EP15719362.4A patent/EP3131547A1/en not_active Withdrawn
- 2015-04-14 SG SG11201610349SA patent/SG11201610349SA/en unknown
- 2015-04-14 CN CN201580031471.1A patent/CN107148270A/zh active Pending
- 2015-04-14 CA CA2945707A patent/CA2945707A1/en not_active Abandoned
-
2017
- 2017-06-12 US US15/619,785 patent/US20170273996A1/en not_active Abandoned
-
2018
- 2018-03-07 HK HK18103256.3A patent/HK1243643A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160008383A1 (en) | 2016-01-14 |
| JP6662789B2 (ja) | 2020-03-11 |
| HK1243643A1 (zh) | 2018-07-20 |
| AU2015247859B2 (en) | 2020-03-26 |
| KR20170003576A (ko) | 2017-01-09 |
| JP2017511372A (ja) | 2017-04-20 |
| US20170273996A1 (en) | 2017-09-28 |
| CN107148270A (zh) | 2017-09-08 |
| CA2945707A1 (en) | 2015-10-22 |
| WO2015160796A1 (en) | 2015-10-22 |
| EP3131547A1 (en) | 2017-02-22 |
| AU2015247859A1 (en) | 2016-12-01 |
| US9675627B2 (en) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1248807A1 (zh) | 激活素-actrii拮抗劑及用於治療貧血症的用途 | |
| SG11201609734VA (en) | Devices and methods for treating lower extremity vasculature | |
| AU362358S (en) | Pet treat | |
| GB201502084D0 (en) | Catheter devices and related methods | |
| PL3189074T3 (pl) | Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom | |
| IL251660A0 (en) | A method for measured dosage and a mechanism for its application | |
| IL251616A0 (en) | Methods and compounds for the treatment and prevention of muscle loss | |
| PL3186013T3 (pl) | Urządzenie do obróbki przedmiotów | |
| IL250114B (en) | Methods and compositions for the treatment of HIV-related diseases | |
| IL252904A0 (en) | Methods and factors for treating diseases | |
| ZA201703771B (en) | Compositions and methods for treating hyperkalemia | |
| HK1243643A1 (zh) | 用於治療和/或預防腦淀粉樣變性的給藥方案 | |
| IL246637A0 (en) | Preparations and methods for the treatment of intracerebral hemorrhage | |
| GB201604707D0 (en) | Elevator exclusive usage method and device | |
| GB201400311D0 (en) | Treating Susceptibility | |
| IL255012A0 (en) | Preparations and methods for treating skin conditions | |
| IL248506A0 (en) | Dosage regimens of nitisinone for the treatment of alkeptonuria | |
| SG11201804140PA (en) | Acidic-gas treating agent and acidic-gas treating method | |
| HUP1600390A2 (hu) | Kumulatív hatású páncéltörõ eszközök hatásának fokozása megfelelõ robbanóanyag és bélésanyag alkalmazásával és ilyen anyagok | |
| ZA201509077B (en) | Safety net | |
| GB201407949D0 (en) | Compositions and methods for treating biofilms | |
| SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes |